SO
AXSM icon

STRS Ohio’s Axsome Therapeutics AXSM Stock Holding History

STRS Ohio’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Sell
909
-9,591
-91% -$2.08M ﹤0.01% 1548
2026
Q1 		$1.77M Sell
10,500
-300
-3% -$51.8K 0.01% 594
2025
Q4 		$1.97M Sell
10,800
-1,100
-9% -$154K 0.01% 577
2025
Q3 		$1.45M Sell
11,900
-200
-2% -$22.5K 0.01% 601
2025
Q2 		$1.26M Buy
12,100
+1,700
+16% +$180K ﹤0.01% 834
2025
Q1 		$1.21M Buy
10,400
+5,800
+126% +$661K 0.01% 785
2024
Q4 		$389K Hold
4,600
– – ﹤0.01% 1297
2024
Q3 		$413K Buy
4,600
+1,800
+64% +$157K ﹤0.01% 1338
2024
Q2 		$225K Sell
2,800
-1,600
-36% -$118K ﹤0.01% 1534
2024
Q1 		$351K Sell
4,400
-1,600
-27% -$134K ﹤0.01% 1390
2023
Q4 		$477K Sell
6,000
-3,500
-37% -$234K ﹤0.01% 1300
2023
Q3 		$663K Buy
9,500
+2,100
+28% +$157K ﹤0.01% 1075
2023
Q2 		$531K Buy
7,400
+700
+10% +$51.6K ﹤0.01% 1254
2023
Q1 		$413K Buy
6,700
+2,900
+76% +$191K ﹤0.01% 1401
2022
Q4 		$293K Buy
+3,800
New +$227K ﹤0.01% 1504
2022
Q1 		– Sell
-4,600
Closed -$173K – 2142
2021
Q4 		$173K Sell
4,600
-800
-15% -$29.4K ﹤0.01% 1769
2021
Q3 		$177K Buy
+5,400
New +$210K ﹤0.01% 1805
2021
Q1 		– Sell
-1,100
Closed -$89K – 2176
2020
Q4 		$89K Sell
1,100
-7,700
-88% -$576K ﹤0.01% 1908
2020
Q3 		$627K Hold
8,800
– – ﹤0.01% 1200
2020
Q2 		$724K Buy
8,800
+5,000
+132% +$385K ﹤0.01% 1062
2020
Q1 		$223K Buy
+3,800
New +$310K ﹤0.01% 1518
2017
Q2 		– Sell
-3,600
Closed -$14K – 1937
2017
Q1 		$14K Hold
3,600
– – ﹤0.01% 1839
2016
Q4 		$24K Hold
3,600
– – ﹤0.01% 1846
2016
Q3 		$28K Sell
3,600
-100
-3% -$757 ﹤0.01% 1819
2016
Q2 		$27K Buy
+3,700
New +$34.1K ﹤0.01% 1841

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

STRS Ohio's AXSM Position: Q2 2026 in Review

STRS Ohio reduced its Axsome Therapeutics (AXSM) stake by 91% in Q2 2026, selling an estimated $2.08M and leaving 909 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

STRS Ohio first reported a position in AXSM in Q2 2016 and has held it in 25 quarters since. The position peaked at $1.97M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • STRS Ohio held 909 shares of Axsome Therapeutics worth $222K as of Q2 2026.
  • STRS Ohio sold 9,591 Axsome Therapeutics shares in Q2 2026, an estimated $2.08M.
  • Axsome Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1548 holding.
  • STRS Ohio first reported a position in Axsome Therapeutics in Q2 2016 and has held it in 25 quarters since.
  • STRS Ohio's Axsome Therapeutics position peaked at $1.97M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.